PIPERACILLIN AND TAZOBACTAM
Generic: PIPERACILLIN AND TAZOBACTAM
HospiraManufacturer
INTRAVENOUS, PARENTERALRoute
PIPERACILLIN SODIUMActive Substance
2010-10-21Original Approval
PIPERACILLIN AND TAZOBACTAM is FDA application ANDA065362, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2018-07-02
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: AuromedPresence of Particulate Matter: identified as glass and silicone material
Class I2018-05-01
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx OnlyPresence of Particulate Matter: confirmed customer report for presence of visible particulate matter
Top Reported Reactions
1
DRUG INEFFECTIVE
3,061 reports
2
OFF LABEL USE
2,648 reports
3
ACUTE KIDNEY INJURY
2,093 reports
4
PYREXIA
1,770 reports
5
CONDITION AGGRAVATED
1,146 reports
6
DIARRHOEA
1,110 reports
7
THROMBOCYTOPENIA
1,056 reports
8
PNEUMONIA
1,008 reports
9
NEUTROPENIA
974 reports
10
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
960 reports